Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Marques, Cynthia
NCT06329453: Intestinal Immunity in Neurologic Disease	Recruiting	N/A	100	US	Colon Tissue Biopsy	Yale University	Multiple Sclerosis, Parkinson Disease, REM Sleep Behavior Disorder	08/27	08/27
DREAM, NCT05787795: Identifying and Characterizing Preclinical MS	Recruiting	N/A	1000	US	biological samples	Yale University, Roche-Genentech	Multiple Sclerosis	06/32	06/33
Longbrake, Erin
CELLO, NCT04877457: Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.	Terminated	4	3	US	Ocrelizumab, Placebo	Yale University, Genentech, Inc.	Radiologically Isolated Syndrome, Multiple Sclerosis	06/23	06/23
NCT05285891: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis	Recruiting	4	123	US	Ocrelizumab, Ocrevus, Placebo for Ocrelizumab	National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence (ACE), Rho Federal Systems Division, Inc., Genentech, Inc.	Multiple Sclerosis	08/28	08/28
ExTINGUSH, NCT04372615: The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis	Recruiting	2	116	Europe, US	Inebilizumab, UPLIZNA, Placebo	University of Utah	Autoimmune Encephalitis, Encephalitis	10/25	08/26
NCT06329453: Intestinal Immunity in Neurologic Disease	Recruiting	N/A	100	US	Colon Tissue Biopsy	Yale University	Multiple Sclerosis, Parkinson Disease, REM Sleep Behavior Disorder	08/27	08/27
NCT05286242: Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients	Active, not recruiting	N/A	400	US	COVID19 vaccine	Yale University, National Institute of Allergy and Infectious Diseases (NIAID), Robert Leet and Clara Guthrie Patterson Trust	Multiple Sclerosis, Autoimmune Blistering Disease, B-Cell Deficiency	05/26	06/26
DREAM, NCT05787795: Identifying and Characterizing Preclinical MS	Recruiting	N/A	1000	US	biological samples	Yale University, Roche-Genentech	Multiple Sclerosis	06/32	06/33